Live Breaking News & Updates on Equity In Clinical Research

Stay updated with breaking news from Equity in clinical research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Practice Follows Principles More Inclusive Patient-Centered Development Commercialization


By Hilary Wilson, Boehringer Ingelheim, Cleonette D. Cudjoe, Patient Advocate, and Jen Horonjeff, Savvy Cooperative
Underrepresentation of Black and Indigenous people of color (BIPOC) and other racial and ethnic minorities in clinical trials is a longstanding issue. The disparate impact that COVID-19 has had on BIPOC, Hispanic, Latinx, and Asian communities, combined with the underrepresentation of these subgroups in some COVID-19 clinical trials, has brought a sense of urgency to address this historic challenge. Within the past year, the Pharmaceutical Manufacturers of America (PhRMA) released the first industry-wide principles on clinical trial diversity; the Multi-Regional Clinical Trials Center published the “Achieving Diversity, Inclusion, and Equity in Clinical Research” guidance; and the US FDA released a final guidance to encourage the inclusion of groups that are often overlooked in clinical trials. ....

Cleonetted Cudjoe , America Ph , Hilary Wilson , Jen Horonjeff , Boehringer Ingelheim , Regional Clinical Trials Center , Equity In Clinical Research , Patient Advocate , Pharmaceutical Manufacturers , Multi Regional Clinical Trials Center , அமெரிக்கா பீயெச் , ஹிலாரி வில்சன் , போஹெரிங்கர் இஂகல்‌ஹைம் , பிராந்திய மருத்துவ சோதனைகள் மையம் , நோயாளி வழக்கறிஞர் , மருந்து உற்பத்தியாளர்கள் , பல பிராந்திய மருத்துவ சோதனைகள் மையம் ,